SARS-COV-2 S Trimer Protein (BA.2, HEK293, His)
Based on 1 Customer Validation
The SARS-CoV-2 S glycoprotein is critical in infection, binding to the ACE2 receptor and allowing viral particles to attach to the host cell membrane. Cleavage of S2/S2′ triggers cell membrane fusion or internalization via endocytosis. SARS-COV-2 S trimer Protein (BA.2, HEK293, His) is the recombinant virus-derived SARS-COV-2 S trimer protein, expressed by HEK293, with C-His labeled tag, mutations, and furin cleavage site mutants.
- Species: Virus
- Source: HEK293
-
Storage:Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
Biological Activity
Description
The SARS-CoV-2 S glycoprotein is critical in infection, binding to the ACE2 receptor and allowing viral particles to attach to the host cell membrane. Cleavage of S2/S2′ triggers cell membrane fusion or internalization via endocytosis. SARS-COV-2 S trimer Protein (BA.2, HEK293, His) is the recombinant virus-derived SARS-COV-2 S trimer protein, expressed by HEK293, with C-His labeled tag, mutations, and furin cleavage site mutants.
Background
The SARS-CoV-2 S glycoprotein plays a crucial role in infection by attaching the virion to the host cell membrane through interaction with the primary receptor, host ACE2. Upon cleavage of S2/S2', binding to the ACE2 receptor initiates either direct fusion at the cell membrane or internalization of the virus via endocytosis, leading to fusion of the virion membrane with the host endosomal membrane. Additionally, the glycoprotein may utilize NRP1/NRP2 and integrin as alternative entry receptors, possibly explaining the virus's tropism in human olfactory epithelial cells. The stalk domain of S exhibits three hinges, providing unexpected orientational freedom to the head. Acting as a class I viral fusion protein, the glycoprotein undergoes an extensive and irreversible conformational change during virus entry, triggered by host TMPRSS2 or CSTL, leading to fusion of the viral envelope with the cellular cytoplasmic membrane and release of viral genomic RNA into the host cell cytoplasm. The glycoprotein exhibits at least three conformational states: pre-fusion native, pre-hairpin intermediate, and post-fusion hairpin, with the coiled coil regions adopting a trimer-of-hairpins structure during fusion, facilitating the apposition and subsequent fusion of viral and target cell membranes.
Verified Bioactivity
Immobilized ACE2 Protein, Human, Recombinant (mFc Tag) at 2 μg/mL (100 μL/well) can bind SARS-CoV 2 (BA.2) Spike S1+S2 trimer Protein (ECD, His Tag), the EC50 is 11.3ng/mL
Technical Parameters
-
Species Virus
-
Source HEK293
-
Tag C-His
-
Accession
P0DTC2/YP_009724390.1 (V16-Q1208, T19I, L24S, ΔP25-A27, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K, R682G, R683S, R685S, F817P, A892P, A899P, A942P, K986P, V987P)
-
Gene ID43740568
-
Molecular Construction
-
N-term
-
Spike Trimer (V16-Q1208, with multiple mutations)
Accession # P0DTC2/YP_009724390.1 -
T4 fibritin trimerization motif-10*His
-
C-term
-
-
Protein Length
Partial Extracellular Domain
-
Mutation
T19I, L24S, ΔP25-A27, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K; R682G, R683S, R685S; F817P, A892P, A899P, A942P, K986P, V987P
-
Mutation Definition
T19I, L24S, ΔP25-A27, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K: SARS-CoV-2 Omicron BA.2 variant-associated mutations (Pango lineage BA.2);
R682G, R683S, R685S: Furin cleavage site ablation;
F817P, A892P, A899P, A942P, K986P, V987P: Prefusion trimer stabilization -
Synonyms
S protein; Spike glycoprotein; S glycoprotein; COVID-19; BA.2
-
Predicted Molecular Mass
136.5 kDa
-
Molecular Weight
Approximately 150-200 kDa, based on SDS-PAGE under reducing conditions.
-
Purity
≥ 90%, as determined by reducing SDS-PAGE.
Product Properties
Solution
Supplied as a 0.2 μm filtered solution of sodium citrate buffer system, pH 6.0.
<1 EU/μg, determined by LAL method.
Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
Shipping with dry ice.
Documentation
-
Data Sheet (235 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)